XSES
NPL
Market cap23mUSD
Dec 26, Last price
0.23SGD
Name
Niks Professional Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Niks Professional Ltd., operating with its subsidiaries, delivers family-focused dermatology and aesthetic healthcare solutions in Singapore under the NIKS brand. The company structures its operations across three primary segments: Clinics, Retail, and Headquarters. Its service offerings encompass treatments for common skin ailments such as acne, eczema, and pigmentation, alongside a suite of non-surgical and minimally invasive aesthetic procedures, including intense pulsed light therapy, diverse laser treatments, and injectables. Beyond clinical services, NPL also distributes a range of medical-grade skincare products to a varied clientele, from hospitals and clinics to pharmacies, retail outlets, medical professionals, and direct consumers, leveraging regional agents, its own distribution channels, and e-commerce platforms. Additionally, the company provides salon services, featuring therapeutic facial treatments, specialized eye care, acne and comedone removal, and microdermabrasion. Niks Professional Ltd. was founded in 1998 and maintains its headquarters in Singapore.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||